Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISTART: Zubsolv vs Suboxone in Opioid Dependence
NCT01908842Phase 3Completed
- Sponsor
- Orexo AB
- Start
- Aug 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Orexo AB. Started Aug 2013; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01908842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908842.